Evidence map›Paper›PMID 28194241›Full record

ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2016

Short-term outcomes of the new intragastric balloon End-Ball

Marek Buzga, Tomas Kupka, Milan Siroky, Habib Narwan, Evzen Machytka, Pavol Holeczy, Zdeněk Švagera

Open access · goldAbstract read
In one paragraph

Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mechanical intestinal obstruction caused by displacement of a stomach balloon - case report.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2018
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Marek BuzgaDepartment of Physiology and Pathophysiology, University of Ostrava, Ostrava, Czech Republic; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Tomas KupkaDepartment of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic; Department of Internal Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
Milan SirokyGastroenterology Ltd, Hradec Králové, Czech Republic.
Habib NarwanDepartment of Gastroenterology, Abawi Ltd, Bratislava, Slovak Republic.
Evzen MachytkaDepartment of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic; Department of Internal Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
Pavol HoleczyDepartment of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Zdeněk ŠvageraInstitute of Laboratory Diagnostics, University Hospital Ostrava, Ostrava, Czech Republic.
University of Ostrava · CZUniversity Hospital Hradec Králové · CZUniversity Hospital Ostrava · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIntragastric balloons (IGBs) have been successfully used to treat obesity for the last 18 years. These balloons are made of different materials and filled with either air or saline. It seems that balloons filled with saline result in more effective weight loss, but are associated with worse tolerance after implantation. In contrast, balloons filled with air are associated with excellent tolerance, but result in less effective weight loss.

aimTo report the early safety and effectiveness results of the End-Ball MATERIAL AND

methodsTwenty obese patients (mean age: 40.5 years; mean body mass index: 34.8 kg/m

resultsNo serious adverse events occurred during treatment. Patients experienced varying degrees of nausea, vomiting (mean: 3.7 times the first day), and abdominal pain after implantation. Six months (23-29 weeks) after End-Ball

conclusionsThe End-Ball

Indexed as

End-Ball®intragastric balloonobesitysafetyweight loss

Identifiers

PMID28194241
PMCPMC5299079
OpenAlexW2589017529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.